An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.
about
Double unit grafts successfully extend the application of umbilical cord blood transplantation in adults with acute leukemiaDominant unit CD34+ cell dose predicts engraftment after double-unit cord blood transplantation and is influenced by bank practice.Rapid induction of single donor chimerism after double umbilical cord blood transplantation preceded by reduced intensity conditioning: results of the HOVON 106 phase II study.Progenitor cell dose determines the pace and completeness of engraftment in a xenograft model for cord blood transplantation.Influence of infused cell dose and HLA match on engraftment after double-unit cord blood allografts.KIR and HLA genotypes have no identifiable role in single-unit dominance following double-unit umbilical cord blood transplantationReduced late mortality risk contributes to similar survival after double-unit cord blood transplantation compared with related and unrelated donor hematopoietic stem cell transplantation.HLA mismatch direction in cord blood transplantation: impact on outcome and implications for cord blood unit selection.Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse Model.Better allele-level matching improves transplant-related mortality after double cord blood transplantation.Beneficial effects of non-matched allogeneic cord blood mononuclear cells upon patients with idiopathic osteoporosis.Association between Nondominant Unit Total Nucleated Cell Dose and Engraftment in Myeloablative Double-Unit Cord Blood Transplantation.Factors predicting single-unit predominance after double umbilical cord blood transplantation.Early CD3 peripheral blood chimerism predicts the long-term engrafting unit following myeloablative double-cord blood transplantation.Humanized mouse models of HIV infectionSustained donor engraftment in recipients of double-unit cord blood transplantation is possible despite donor-specific human leukoctye antigen antibodiesClinical utilization of cord blood over human health: experience of stem cell transplantation and cell therapy using cord blood in Korea.An overview of the progress on double umbilical cord blood transplantation.Double cord blood transplantation: co-operation or competition?Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.High affinity and covalent-binding microtubule stabilizing agents show activity in chemotherapy-resistant acute myeloid leukemia cells.Validation of human monoclonal HLA Class I antibodies to evaluate the kinetics of donor chimerism in different cell subsets after double-cord-blood transplantation in the NOD/SCID model.In situ chimerism after double cord blood transplantation.Haplo-cord transplant: HLA-matching determines graft dominance.
P2860
Q30415126-BA545BE7-C747-4A7C-965C-497B8F1C42A5Q33456839-1D9E1709-29AE-4D7D-97A2-0BDA336003BAQ34463602-40B9CBD5-2E64-4FD1-AD16-9A7E81DB56F6Q34541687-749A565E-B4AA-4C7E-B2F4-849BC4D33230Q34754318-70B45C08-EABB-43F8-8FED-BD1E824FF727Q34860237-C6547A11-8494-4CFE-AE88-6A180F5FC417Q35167190-1E80FBB7-0CBA-4316-B250-926523231874Q35794126-95739551-DD61-47B9-B338-506D927A883CQ35805902-959E49D7-4539-4553-A03D-AD841893C90EQ36115699-9659998A-3DD9-4DB2-BFCF-668065CA091DQ36127774-9C2FB53E-B5F5-48A7-8D2A-67D65E2ED99BQ36157327-BCBBC35B-DFDB-49D8-AEA3-F60925FBDF62Q36664471-5632CDE1-5A47-4C42-871C-E7FB9151115EQ36923420-4D6A9B75-E3F3-4D2D-A03C-AF85F1A05207Q37089865-28A0FDF8-487B-4F6E-A75B-3AA99FAE995BQ37699562-F7E8D8E7-7A58-473D-A6C0-F97DC1F8A708Q37725142-4AC1E5ED-7BDE-4E88-AE25-FA6617D46606Q37872506-1F9127E1-00DB-481F-9106-360A9773BF17Q39805764-5D11149A-22CA-4484-B2AC-6468B91A4AAFQ40012419-B610E9EF-B4B7-4341-8688-FE5898E00841Q40639032-67393ED6-5D9E-455D-B35B-F6713EF6299FQ44792246-E9A24D98-966E-4139-934E-CBAE1DDAC3EAQ54250637-20055A9D-2CC2-4175-A5AA-AB2198A8E43DQ55261861-E7E9C527-5693-44FD-A0B3-26278D54C096
P2860
An in vivo model of double-unit cord blood transplantation that correlates with clinical engraftment.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An in vivo model of double-uni ...... tes with clinical engraftment.
@ast
An in vivo model of double-uni ...... tes with clinical engraftment.
@en
An in vivo model of double-uni ...... tes with clinical engraftment.
@nl
type
label
An in vivo model of double-uni ...... tes with clinical engraftment.
@ast
An in vivo model of double-uni ...... tes with clinical engraftment.
@en
An in vivo model of double-uni ...... tes with clinical engraftment.
@nl
prefLabel
An in vivo model of double-uni ...... tes with clinical engraftment.
@ast
An in vivo model of double-uni ...... tes with clinical engraftment.
@en
An in vivo model of double-uni ...... tes with clinical engraftment.
@nl
P2093
P2860
P1433
P1476
An in vivo model of double-uni ...... ates with clinical engraftment
@en
P2093
Glenn Heller
Juliet N Barker
Lamis K Eldjerou
Malcolm A Moore
Maria E Arcila
Richard J O'Reilly
Sonali Chaudhury
P2860
P304
P356
10.1182/BLOOD-2010-03-276212
P407
P577
2010-06-29T00:00:00Z